Duodenal gastrointestinal stromal tumors (DGISTs) represent a rare subset of mesenchymal neoplasms of the gastrointestinal tract, accounting for approximately 3–5% of all gastrointestinal ...

According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...

The median tumor size was 10.7 cm (range, 1.7-35 cm). Most patients with GIST (51%) had their primary disease located in the stomach followed by small intestine, including both duodenum and jejunum, ...

In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...

Time to secondary resistance (TSR) after interruption of imatinib (IM) in advanced GIST: Updated results of the prospective French Sarcoma Group randomized phase III trial on long-term survival. This ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Familial adenomatous polyposis (FAP) is an inherited gastrointestinal ... duodenal adenoma formation in patients with FAP. Various intrinsic factors, including the metabolic state of cancer ...